Current Landscape and Future Directions of Biomarkers for Predicting Responses to Immune Checkpoint Inhibitors

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s167400
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Current Evidence and Future Perspectives of Immune-Checkpoint Inhibitors in Unresectable Malignant Pleural Mesothelioma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology

Cancer cytopathology
Cancer ResearchOncology
2017English

Predicting Air Quality: Current Status and Future Directions

NATO Science for Peace and Security Series
English

Systemic Immunological Biomarkers of Clinical Responses in Immune Checkpoint Blockade Therapies

Lung Cancer Management
2018English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Serum Biomarkers of Drug-Induced Liver Injury: Current Status and Future Directions

Journal of Digestive Diseases
Gastroenterology
2018English

The Changing Landscape of Prostate Cancer Chemoprevention: Current Strategies and Future Directions

2012English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy